Shaan Syed Khurshid, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 35 | 2024 | 5209 | 3.980 |
Why?
|
Electrocardiography | 17 | 2024 | 6414 | 2.760 |
Why?
|
Cardiomyopathies | 10 | 2023 | 1952 | 2.390 |
Why?
|
Stroke | 15 | 2024 | 9962 | 1.150 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2557 | 1.120 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2023 | 2128 | 1.010 |
Why?
|
Pacemaker, Artificial | 2 | 2023 | 815 | 0.880 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2023 | 866 | 0.880 |
Why?
|
Heart Ventricles | 5 | 2023 | 3811 | 0.710 |
Why?
|
Brugada Syndrome | 1 | 2021 | 95 | 0.710 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2255 | 0.690 |
Why?
|
Atrial Flutter | 1 | 2022 | 258 | 0.690 |
Why?
|
Cardiovascular System | 2 | 2024 | 850 | 0.670 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 978 | 0.670 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 578 | 0.650 |
Why?
|
Exercise | 3 | 2024 | 5787 | 0.630 |
Why?
|
Heart Conduction System | 3 | 2023 | 1015 | 0.620 |
Why?
|
Electric Countershock | 1 | 2021 | 537 | 0.610 |
Why?
|
Perceptual Disorders | 2 | 2011 | 197 | 0.600 |
Why?
|
Risk Assessment | 16 | 2024 | 24123 | 0.580 |
Why?
|
Cryosurgery | 1 | 2022 | 475 | 0.560 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2017 | 122 | 0.540 |
Why?
|
Electric Stimulation Therapy | 1 | 2022 | 613 | 0.530 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 854 | 0.520 |
Why?
|
Ventricular Function, Left | 7 | 2023 | 3880 | 0.510 |
Why?
|
Phenethylamines | 1 | 2015 | 95 | 0.490 |
Why?
|
Ventricular Function, Right | 3 | 2023 | 610 | 0.480 |
Why?
|
Heart Failure | 9 | 2024 | 11847 | 0.470 |
Why?
|
Incidence | 13 | 2024 | 21392 | 0.460 |
Why?
|
Quality Indicators, Health Care | 1 | 2024 | 1824 | 0.450 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1499 | 0.450 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 553 | 0.390 |
Why?
|
Risk Factors | 22 | 2024 | 74359 | 0.390 |
Why?
|
Models, Genetic | 1 | 2021 | 3442 | 0.380 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2001 | 0.380 |
Why?
|
Catheter Ablation | 2 | 2022 | 2758 | 0.360 |
Why?
|
Middle Aged | 35 | 2024 | 220352 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 784 | 0.360 |
Why?
|
Anticoagulants | 4 | 2020 | 4897 | 0.350 |
Why?
|
Humans | 68 | 2024 | 760621 | 0.350 |
Why?
|
Electronic Health Records | 7 | 2024 | 4775 | 0.340 |
Why?
|
Reperfusion | 1 | 2011 | 271 | 0.340 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12626 | 0.340 |
Why?
|
Mass Screening | 4 | 2024 | 5423 | 0.330 |
Why?
|
Male | 41 | 2024 | 359744 | 0.320 |
Why?
|
Aged | 30 | 2024 | 169152 | 0.320 |
Why?
|
Vision, Monocular | 1 | 2009 | 71 | 0.320 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15289 | 0.320 |
Why?
|
Bradycardia | 2 | 2022 | 299 | 0.310 |
Why?
|
Female | 37 | 2024 | 391270 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2020 | 3127 | 0.270 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15757 | 0.260 |
Why?
|
Aorta | 2 | 2024 | 2039 | 0.260 |
Why?
|
Algorithms | 6 | 2024 | 13981 | 0.250 |
Why?
|
Time Factors | 7 | 2024 | 40165 | 0.250 |
Why?
|
Sulfonamides | 1 | 2015 | 1977 | 0.240 |
Why?
|
Heart | 5 | 2024 | 4393 | 0.240 |
Why?
|
Stroke Volume | 6 | 2024 | 5523 | 0.240 |
Why?
|
Heart Rate | 3 | 2024 | 4179 | 0.230 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2023 | 162 | 0.200 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1273 | 0.200 |
Why?
|
Aged, 80 and over | 12 | 2022 | 58995 | 0.190 |
Why?
|
Age Factors | 5 | 2024 | 18416 | 0.190 |
Why?
|
Tachycardia, Supraventricular | 1 | 2024 | 274 | 0.190 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 648 | 0.180 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2733 | 0.180 |
Why?
|
Retrospective Studies | 11 | 2023 | 80372 | 0.180 |
Why?
|
Endophenotypes | 1 | 2022 | 255 | 0.180 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5508 | 0.170 |
Why?
|
Action Potentials | 2 | 2018 | 1816 | 0.170 |
Why?
|
Survival Rate | 4 | 2021 | 12808 | 0.160 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 819 | 0.160 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1097 | 0.160 |
Why?
|
Tricuspid Valve | 1 | 2022 | 409 | 0.160 |
Why?
|
Prospective Studies | 6 | 2024 | 54303 | 0.160 |
Why?
|
Attention | 1 | 2009 | 2387 | 0.160 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39261 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2023 | 65017 | 0.160 |
Why?
|
Prevalence | 3 | 2023 | 15687 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 587 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 615 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2024 | 1261 | 0.150 |
Why?
|
Heart Atria | 1 | 2024 | 1346 | 0.150 |
Why?
|
Long QT Syndrome | 1 | 2022 | 466 | 0.150 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1843 | 0.140 |
Why?
|
Electronic Prescribing | 1 | 2018 | 114 | 0.140 |
Why?
|
Models, Economic | 1 | 2021 | 719 | 0.140 |
Why?
|
Natural Language Processing | 2 | 2023 | 1135 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2018 | 245 | 0.130 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 718 | 0.130 |
Why?
|
Exercise Test | 1 | 2024 | 2128 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 1046 | 0.130 |
Why?
|
Birth Weight | 1 | 2024 | 2097 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 844 | 0.130 |
Why?
|
Echocardiography | 3 | 2022 | 4981 | 0.130 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 36 | 0.130 |
Why?
|
Gestational Age | 1 | 2024 | 3565 | 0.120 |
Why?
|
Equipment Design | 1 | 2023 | 3520 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2009 | 3976 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1724 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1617 | 0.120 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6659 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 522 | 0.110 |
Why?
|
Pennsylvania | 1 | 2014 | 615 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3765 | 0.100 |
Why?
|
Administration, Oral | 2 | 2018 | 4035 | 0.100 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2571 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12531 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12159 | 0.100 |
Why?
|
Primary Health Care | 3 | 2023 | 4647 | 0.100 |
Why?
|
Equipment Failure | 1 | 2014 | 577 | 0.100 |
Why?
|
Adult | 12 | 2024 | 219994 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2717 | 0.090 |
Why?
|
Recovery of Function | 1 | 2021 | 2985 | 0.090 |
Why?
|
Cohort Studies | 4 | 2023 | 41335 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 17790 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3465 | 0.090 |
Why?
|
Hemorrhage | 2 | 2022 | 3600 | 0.090 |
Why?
|
Public Health | 1 | 2023 | 2653 | 0.080 |
Why?
|
Eye Protective Devices | 1 | 2009 | 33 | 0.080 |
Why?
|
Recurrence | 3 | 2020 | 8482 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2809 | 0.080 |
Why?
|
Spatial Behavior | 1 | 2009 | 88 | 0.080 |
Why?
|
Sensory Deprivation | 1 | 2009 | 106 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3258 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2283 | 0.070 |
Why?
|
Prognosis | 3 | 2024 | 29658 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4013 | 0.070 |
Why?
|
Orientation | 1 | 2009 | 321 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 7021 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3896 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1303 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3517 | 0.070 |
Why?
|
Space Perception | 1 | 2009 | 464 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4673 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15840 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8950 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2011 | 1967 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6828 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8803 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.060 |
Why?
|
Brain | 1 | 2011 | 26951 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10551 | 0.060 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2024 | 149 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2024 | 527 | 0.050 |
Why?
|
Atrial Function, Left | 1 | 2024 | 186 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 77 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2253 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1296 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 208 | 0.050 |
Why?
|
Visual Fields | 1 | 2009 | 1054 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11891 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13314 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 187 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1878 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36290 | 0.050 |
Why?
|
Registries | 3 | 2023 | 8469 | 0.040 |
Why?
|
Myocardium | 2 | 2023 | 4700 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9287 | 0.040 |
Why?
|
United States | 4 | 2021 | 72461 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25942 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 777 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1298 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 998 | 0.040 |
Why?
|
Automation | 1 | 2020 | 580 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14495 | 0.040 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1365 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 698 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2042 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1921 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3301 | 0.030 |
Why?
|
Genetic Loci | 1 | 2024 | 2618 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 665 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 782 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16546 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 2015 | 228 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1739 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2101 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1570 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3568 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1047 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3334 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4611 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1306 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14660 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12965 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5325 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10547 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22053 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2290 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8035 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20080 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3201 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 5990 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15789 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12914 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26181 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8525 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3836 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9073 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8594 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20509 | 0.010 |
Why?
|